100 related articles for article (PubMed ID: 32053979)
1. Atypical PKC, PKCλ/ι, activates β-secretase and increases Aβ
Sajan MP; Hansen BC; Higgs MG; Kahn CR; Braun U; Leitges M; Park CR; Diamond DM; Farese RV
Neurobiol Aging; 2018 Jan; 61():225-237. PubMed ID: 29032894
[TBL] [Abstract][Full Text] [Related]
2. Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.
Nelson TJ; Cui C; Luo Y; Alkon DL
J Biol Chem; 2009 Dec; 284(50):34514-21. PubMed ID: 19850930
[TBL] [Abstract][Full Text] [Related]
3. Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer's Disease.
Rosenberry TL; Zhou HX; Stagg SM; Paravastu AK
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557940
[TBL] [Abstract][Full Text] [Related]
4. Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease.
Yahata N; Asai M; Kitaoka S; Takahashi K; Asaka I; Hioki H; Kaneko T; Maruyama K; Saido TC; Nakahata T; Asada T; Yamanaka S; Iwata N; Inoue H
PLoS One; 2011; 6(9):e25788. PubMed ID: 21984949
[TBL] [Abstract][Full Text] [Related]
5. Aftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease?
Hochard A; Oumata N; Bettayeb K; Gloulou O; Fant X; Durieu E; Buron N; Porceddu M; Borgne-Sanchez A; Galons H; Flajolet M; Meijer L
J Alzheimers Dis; 2013; 35(1):107-20. PubMed ID: 23364140
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Characterization of Andrographolide Derivatives as Regulators of βAPP Processing in Human Cells.
Dey A; Chen R; Li F; Maitra S; Hernandez JF; Zhou GC; Vincent B
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946739
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of long-term antioxidant diet and behavioral enrichment on beta-amyloid load and non-amyloidogenic processing in aged canines.
Pop V; Head E; Hill MA; Gillen D; Berchtold NC; Muggenburg BA; Milgram NW; Murphy MP; Cotman CW
J Neurosci; 2010 Jul; 30(29):9831-9. PubMed ID: 20660265
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
Gong Y; Chang L; Viola KL; Lacor PN; Lambert MP; Finch CE; Krafft GA; Klein WL
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10417-22. PubMed ID: 12925731
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity.
Malinin NL; Wright S; Seubert P; Schenk D; Griswold-Prenner I
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3058-63. PubMed ID: 15710903
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inducers of Aβ-42 peptide production share a common mechanism of action.
Bettayeb K; Oumata N; Zhang Y; Luo W; Bustos V; Galons H; Greengard P; Meijer L; Flajolet M
FASEB J; 2012 Dec; 26(12):5115-23. PubMed ID: 22972917
[TBL] [Abstract][Full Text] [Related]
11. Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease.
Chiarini A; Armato U; Liu D; Dal Prà I
Front Physiol; 2016; 7():134. PubMed ID: 27199760
[TBL] [Abstract][Full Text] [Related]
12. Protein Kinase C Involvement in Neuroprotective Effects of Thymol and Carvacrol Against Toxicity Induced by Amyloid-β in Rat Hippocampal Neurons.
Azizi Z; Choopani S; Salimi M; Majlessi N; Naghdi N
Basic Clin Neurosci; 2022; 13(3):295-304. PubMed ID: 36457884
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases.
Saito S; Ono K; Tanaka M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142187
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Toxic Amyloid 42 Oligomers in Rat Primary Cerebral Cortex Cells and Human iPS-derived Neurons Treated with 10-Me-Aplog-1, a New PKC Activator.
Murakami K; Yoshimura M; Nakagawa S; Kume T; Kondo T; Inoue H; Irie K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053979
[TBL] [Abstract][Full Text] [Related]
15. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
[TBL] [Abstract][Full Text] [Related]
16. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently.
Fu H; Dou J; Li W; Cui W; Mak S; Hu Q; Luo J; Lam CS; Pang Y; Youdim MB; Han Y
Eur J Pharmacol; 2009 Nov; 623(1-3):14-21. PubMed ID: 19765582
[TBL] [Abstract][Full Text] [Related]
17. Bryostatin-1 vs. TPPB: dose-dependent APP processing and PKC-α, -δ, and -ε isoform activation in SH-SY5Y neuronal cells.
Yi P; Schrott L; Castor TP; Alexander JS
J Mol Neurosci; 2012 Sep; 48(1):234-44. PubMed ID: 22700373
[TBL] [Abstract][Full Text] [Related]
18. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
